U.S. market Closed. Opens in 17 hours 8 minutes

DVAX | Dynavax Technologies Corporation Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 11.03 - 11.24
52 Week Range 9.74 - 15.15
Beta 1.32
Implied Volatility 10.32%
IV Rank 31.12%
Day's Volume 1,183,187
Average Volume 2,255,761
Shares Outstanding 131,044,000
Market Cap 1,461,140,600
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 2004-02-19
Valuation
Profitability
Growth
Health
P/E Ratio 85.77
Forward P/E Ratio N/A
EPS 0.13
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 408
Country USA
Website DVAX
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
DVAX's peers: ALKS, AMRX, AQST, AVDL, NBIX, ITCI, DCPH, AMPH, LNTH, ANIP, IRWD, PCRX, COLL, EGRX, EBS, DRRX, KALA, OPTN, ORGO
*Chart delayed
Analyzing fundamentals for DVAX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very good and Health is passable. For more detailed analysis please see DVAX Fundamentals page.

Watching at DVAX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on DVAX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙